LATEST NEWS
Gedeon Richter and Myovant Sciences Enter into Exclusive License Agreement to Commercialize Relugolix Combination Tablet for Uterine Fibroids and Endometriosis in Certain Territories Outside the U.S.
in News, Press Releases onRead more31 March 2020 Budapest, Hungary and Basel, Switzerland – Myovant Sciences (NYSE:MYOV), a healthcare company focused on developing innovative…
0Richter announces the acquisition of Finox Holding
in News, Press Releases onRead more30 June 2016 Richter announces the acquisition of Finox Holding for a consideration of CHF190 million. Finox Holding, a…
LATEST PUBLICATIONS
Careers
A career at Preglem® is more than just a job. It gives you the opportunity to solve challenging global problems in a way that can change the world.
Contact us
In line with our corporate culture, we treat all information received with full confidentiality.